CVKD

CVKD

USD

Cadrenal Therapeutics Inc. Common Stock

$15.000+0.090 (0.604%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$14.910

High

$15.000

Low

$14.625

Volume

0.01M

Company Fundamentals

Market Cap

29.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.02M

Exchange

NCM

Currency

USD

52-Week Range

Low $5.7Current $15.000High $22.901

Related News

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Cadrenal Therapeutics, Maintains $32 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cadrenal Therapeutics with a Buy and maintains $32 price target.

View more
HC Wainwright & Co. Reiterates Buy on Cadrenal Therapeutics, Maintains $32 Price Target
BusinessWire

Cadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug

View more
Cadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness